REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
10/17/2025
Back to search
Official data from USPTO
PHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
10/18/2025
Trademark type
Word
Nice classes
36
Filing date
08/02/2004
Registration date
10/17/2006
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/09/2016
Last transaction
10/18/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2004-10-00
First use in commerce
2004-10-00
Drawing code
4
Owner type
03
Owner location
New York, NY
Examiner
CLAYTON,CHERYL A
Law office
L20
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
M. S. (pessoa física)
Representatives
Dorothy R. Whitney COWAN, LIEBOWITZ & LATMAN, P.C.
Technical classification
Nice Classes
Class 36
Vienna Codes
No Vienna codes available.
Goods and services
Class 36
Financial services in the nature of tradingpurchasingstructuring investment securities for othersadvisory services relating thereto
Publications
History of USPTO decisions and trademark events.
35 publications found
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
07/10/2016
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
07/09/2016
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
07/09/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/09/2016
E89R
TEAS SECTION 8 & 9 RECEIVED
04/19/2016
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
10/17/2015
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
07/16/2012
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
07/16/2012
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/16/2012
E815
TEAS SECTION 8 & 15 RECEIVED
07/09/2012
R.PR
REGISTERED-PRINCIPAL REGISTER
10/17/2006
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
09/11/2006
ALIE
ASSIGNED TO LIE
09/05/2006
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
08/26/2006
SUPC
STATEMENT OF USE PROCESSING COMPLETE
06/15/2006
IUAF
USE AMENDMENT FILED
06/02/2006
EISU
TEAS STATEMENT OF USE RECEIVED
06/02/2006
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
05/23/2006
PUBO
PUBLISHED FOR OPPOSITION
02/28/2006
NPUB
NOTICE OF PUBLICATION
02/08/2006
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
01/13/2006
ALIE
ASSIGNED TO LIE
01/06/2006
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/31/2005
GNEA
EXAMINERS AMENDMENT E-MAILED
12/31/2005
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/31/2005
GNRT
NON-FINAL ACTION E-MAILED
07/26/2005
CNRT
NON-FINAL ACTION WRITTEN
07/26/2005
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
06/24/2005
CWBP
WITHDRAWN BEFORE PUBLICATION
06/03/2005
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/21/2005
ALIE
ASSIGNED TO LIE
03/14/2005
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/07/2005
DOCK
ASSIGNED TO EXAMINER
03/07/2005
NWAP
NEW APPLICATION ENTERED
08/10/2004
Continuous trademark protection
Get notified about every new filing that threatens PHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.